The Pharma Data

DECEMBER 4, 2021

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force (CITF).

Immune Response 52

Immune Response Vaccination Vaccine Antibody 52

pharmaphorum

FEBRUARY 25, 2021

Maryland, US-based company Altimmune is among the biotechs and research labs trying to find more convenient alternatives and believes a nasal vaccine spray that is stable at room temperature could be the answer. A nasal delivery method will also produce an immune response at the point where the virus enters the body.

Vaccination 111

Vaccination Vaccine Immune Response Trials 111

pharmaphorum

MAY 19, 2022

Moderna’s vaccines deliver HIV-specific antigens discovered by researchers at IAVI and Scripps Research that have already been tested in a proof-of-concept study carried out last year using an adjuvant protein vaccine approach. HVAD #HVAD2022 pic.twitter.com/KLrVRXtEAv. — Moderna (@moderna_tx) May 18, 2022.

Vaccination 145

Vaccination Vaccine Trials Immune Response 145

Scienmag

MAY 28, 2021

The drug diABZI — which activates the body’s innate immune response — was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2, according to scientists in the Perelman School of Medicine at the University of Pennsylvania.

Immune Response 71

Immune Response Drugs Scientist Research 71

Scienmag

DECEMBER 14, 2021

COLUMBUS, Ohio – Driving up the immune response at the site of a cancer tumor with nanotechnology may help enhance immunotherapy treatments in advanced stages of the disease, new research in mice suggests.

Immune Response 67

Immune Response Scientist Research 67

Medical Xpress

DECEMBER 19, 2022

Northwestern Medicine scientists have identified a new therapeutic target for tumors and developed a compound which slowed tumor growth and bolsters immune responses in mice, according to research published in Science Advances.

Immune Response 68

Immune Response Scientist Medicine Development 68

Medical Xpress

DECEMBER 1, 2022

In 2021, a group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate containing an adjuvant, a substance that enhances immune responses, elicited durable neutralizing antibody responses to SARS-CoV-2 (..)

Vaccination 72

Vaccination Vaccine Immune Response Containment 72

Scienmag

SEPTEMBER 18, 2020

During this ground-breaking study, scientists from the Spanish National Research Council and the University of Surrey investigated the immune response of […].

Gene 72

Gene Immune Response Scientist Research 72

Pharmaceutical Technology

AUGUST 24, 2022

More than three decades ago, scientists at the National Cancer Institute began exploring ways to fight cancer using the patient’s immune system. Quantifiable results: Researchers can obtain relative percentages and learn the absolute count and number of receptors in a cell. Flow cytometry in biomarker research.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

XTalks

JANUARY 20, 2021

Researchers at KU Leuven in Belgium have found a potential mechanism underlying irritable bowel syndrome (IBS) that involves activation of immune cells primed by past gastrointestinal infections. The research findings were published in the journal Nature. Related: Monitoring Patients with IBS or Kidney Failure?

Immune Response 52

Immune Response Research Allergies Protein 52

Scienmag

JUNE 3, 2021

New research into Alzheimer’s disease (AD) suggests that secondary infections and new inflammatory events amplify the brain’s immune response and affect memory in mice and in humans – even when these secondary events occur outside the brain.

Immune Response 41

Immune Response Scientist Research Allergies 41

XTalks

AUGUST 26, 2020

Increasing research into the gut microbiome has revealed new and emerging roles for the ‘good bacteria’ in our bodies, with the latest being a new study that shows how they can help the immune system attack cancer cells.

Bacteria 52

Bacteria Research Immune Response Scientist 52

XTalks

MAY 30, 2023

Established by the Multiple Sclerosis International Federation (MSIF) in 2009, World MS Day has quickly grown to be an influential movement that brings together various stakeholders that include patients and caregivers, researchers and healthcare professionals across more than 90 countries.

Genetics 98

Genetics Research Immune Response Drugs 98

Delveinsight

AUGUST 27, 2020

Moderna’s COVID-19 vaccine triggers an immune response in older adults. At Northwestern University, the researchers combined chemotherapy with an investigational bromodomain (BET) inhibitor to target breast cancer that had spread to the brain in mouse models. White fat, in contrast, can build up and cause obesity.

Vaccination 53

Vaccination Vaccine Research Trials 53

Cloudbyz

MARCH 5, 2024

They are often used to mimic or enhance natural biological processes, such as immune responses. Immunogenicity : Small Molecules: Generally have a lower risk of inducing an immune response in the body. In both cases, clinical research must be meticulously designed to address these complexities.

Development 97

Development Drugs Immune Response Manufacturing 97

The Pharma Data

JULY 6, 2021

If a virus is disease-causing, the right mutation can allow the virus to escape the immune response by changing the viral pieces the immune system uses to recognize the virus as a threat, pieces scientists call epitopes.

Vaccination 52

Vaccination Vaccine Research Immune Response 52

Sciensano

JULY 5, 2023

Vaccin COVID-19 Event type: symposium Audience: general public health professionals journalist PhD students policy makers scientists Description: Sciensano is pleased to invite you to its BelCoVac symposium, which will focus on studies on the COVID vaccine in Belgium.

Vaccination 52

Vaccination Vaccine Immune Response Antibody 52

Delveinsight

FEBRUARY 11, 2021

Verily collaborates with Janssen to launch COVID-19 immune response study. Verily is partnering with Johnson & Johnson’s Janssen division to witness the body’s earliest immune responses to a coronavirus infection, with people participating in the research from within their homes. .

Gene Therapy 52

Gene Therapy Gene Immune Response In-Vivo 52

The Pharma Data

JUNE 1, 2022

Blocking an immune response-related enzyme holds promise in preventing or treating severe COVID-19 symptoms by reducing inflammation, tissue injury and blood clots in the lungs, new research in mice suggests. The research was published online recently in Proceedings of the National Academy of Sciences.

Immune Response 52

Immune Response Genetic Engineering Research Engineer 52

XTalks

FEBRUARY 19, 2024

In a recent study published by Weill Cornell Medicine in the Journal of Infectious Diseases , researchers have reported the potential of Moderna’s experimental mRNA vaccine in protecting adults against CMV, which could potentially also stop the transmission of the virus from mothers to their infants during pregnancy.

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59

The Pharma Data

DECEMBER 11, 2020

The University of Oxford has regularly appeared in our updates since July 2020, as its team of researchers leads an ongoing clinical trial for the Covid-19 vaccine. More recently, the university has released news of its collaboration with Thermo Fisher Scientific as it looks to discover an immune Covid-19 response pre- and post-vaccination.

Antibody 52

Antibody Vaccination Vaccine Containment 52

The Pharma Data

AUGUST 15, 2021

Even as several safe and effective COVID-19 vaccines are being administered to people worldwide, scientists are still hard at work developing different vaccine strategies that could provide even stronger or longer-lasting immunity against SARS-CoV-2 and its variants.

Protein 52

Protein Vaccination Vaccine Antibody 52

The Pharma Data

AUGUST 22, 2021

. “There’s often a phenomenon that doctors report anecdotally, or that’s mentioned in passing in a particular research paper, and that provides a clue – a hook,” he said. Typically, to find out whether a drug is effective in treating a particular medical condition, scientists develop prospective clinical trials.

Doctors 52

Doctors Doctor Drugs Scientist 52

XTalks

JULY 14, 2021

The sound bytes were taken from remarks made by WHO chief scientist, Dr. Soumya Swaminathan, during the briefing in which she was asked about COVID-19 vaccine boosters. It also green-lighted a Pfizer and AstraZeneca vaccine combination given data and evidence from research studies that support the mix. And the science backs this.

Vaccination 98

Vaccination Vaccine Immune Response FDA Approval 98

The Pharma Data

JANUARY 3, 2021

Weber is a renowned melanoma specialist and leading immunotherapy translational and clinical scientist. We are very honored to have someone of Dr. Zeldis’ caliber lead our scientific research and clinical development teams. At NexImmune, he will oversee all aspects of research and development. GAITHERSBURG, Md.,

Immune Response 40

Immune Response Clinical Trials Clinical Trials Development 40

The Pharma Data

APRIL 8, 2021

Early clinical results are consistent with preclinical studies and suggest THOR-707 (SAR444245) may promote an anti-tumor immune response without alpha-mediated side effects, both alone and in combination with anti-PD-1. Global Head of Research & Development, Sanofi. “The

Immune Response 52

Immune Response Engineer Antibody Genetics 52

XTalks

DECEMBER 12, 2023

The team includes outstanding scientists and researchers around the world who look to push the boundaries of what’s possible to discover the next breakthroughs. It’s all part of a deep-seated commitment to innovation and its role as the company’s growth engine. The science is brilliant.

Medicine 111

Medicine Recombinant Antibody Protein Antibody 111

The Pharma Data

OCTOBER 18, 2021

Northwestern Medicine scientists have shown for the first time that coronavirus vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses. ” Years of HIV research led the team to this discovery. . ” Years of HIV research led the team to this discovery.

Vaccination 40

Vaccination Vaccine Immune Response Antibody 40

Roots Analysis

NOVEMBER 11, 2023

Infantile amnesia, the mysterious phenomenon where memories from early childhood seem to slip away, has long intrigued scientists and psychologists alike. Significance of the Research on Autism Dr. Tomás Ryan, the senior author of the study, emphasized the societal implications of these findings.

Immune Response 40

Immune Response Research Development Scientist 40

Olympian Clinical Research

NOVEMBER 16, 2022

According to the American Academy of Dermatology , scientists believe that when a hair follicle becomes clogged with keratin, bacteria breed within it. HS is believed to develop due to an immune response that generates too much inflammation. More research is still needed to understand the causes of HS fully.

Clinical Research 52

Clinical Research Bacteria Dermatology Immune Response 52

The Pharma Data

JANUARY 22, 2021

As research developments into RNA vaccines help scientists accelerate drug candidates to arm the immune system against coronavirus, Pharma IQ ’s Keeping tabs on Covid-19 update returns with news from some of the biotechnology innovators leading the fight against the global pandemic.

Vaccination 52

Vaccination Vaccine Protein Immune Response 52

The Pharma Data

SEPTEMBER 30, 2021

An expert review by a world group of scientists, including some at the WHO and FDA, concludes that, even for the delta variant, vaccine efficacy against severe COVID is so high that booster doses for the overall population aren’t appropriate at this stage within the pandemic. Considerations in boosting COVID-19 vaccine immune responses.

Vaccination 52

Vaccination Vaccine Antibody Immune Response 52

pharmaphorum

OCTOBER 31, 2022

Yancopoulos continued: “Our scientists realised that the science demanded they adapt these technologies to deliver the first FDA-approved recombinant monoclonal antibody treatment for any viral disease, and they picked one of the most challenging ones in Ebola.”.

Production 52

Production FDA Approval Antibody Gene 52

The Pharma Data

DECEMBER 15, 2020

However, if the immune system malfunctions, it can attack healthy cells, tissues and organs. Researchers are aware of more than 80 diseases that occur when the immune system attacks the body’s own organs, tissues and cells. The human monoclonal antibody targets specific immune plasma cells. It may be life-threatening.

Clinical Trials 52

Clinical Trials Clinical Trials Antibody Trials 52

Delveinsight

AUGUST 6, 2020

By ordering human cells to make the protein, ZyCoV-D could cause an immune response against the coronavirus. Scientists have already isolated many highly potent neutralizing antibodies from patients who recovered from COVID-19. ZyCoV-D is designed to introduce DNA that encodes for a viral protein into human cells.

Allergies 53

Allergies Vaccination Vaccine Gene Therapy 53

The Pharma Data

JANUARY 13, 2021

The vaccine produced an immune response of all 805 clinical trial participants within two months of inoculation, according to results published Jan. The new vaccine is made up of a deactivated cold virus into which scientists cut-and-paste a genetic version of the “spike” protein used by the coronavirus to infect cells.

Vaccination 40

Vaccination Vaccine Trials Immune Response 40

The Pharma Data

OCTOBER 9, 2021

Deucravacitinib (pronounced doo-krav-a-sih-ti-nib) is a first-in-class, oral, selective tyrosine kinase 2 (TYK2) inhibitor with a unique mechanism of action and is the first and only selective TYK2 inhibitor in clinical studies across multiple immune-mediated diseases. Deucravacitinib is not approved for use in any country.

Trials 52

Trials Immune Response Dermatology Clinical Trials 52